U S Global Investors Inc Corcept Therapeutics Inc Transaction History

U S Global Investors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$11.0 - $18.26 $607,860 - $1.01 Million	-55,260 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$10.11 - $14.04 $558,678 - $775,850	55,260 New	55,260 $657,000
Q2 2019 Aug 09, 2019	SELL	$9.78 - $12.76 $431,571 - $563,073	-44,128 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$10.03 - $15.71 $110,149 - $172,527	-10,982 Reduced 19.93%	44,128 $518,000
Q4 2018 Feb 12, 2019	SELL	$11.29 - $17.19 $123,185 - $187,560	-10,911 Reduced 16.53%	55,110 $736,000
Q3 2018 Nov 13, 2018	SELL	$12.27 - $15.65 $355,572 - $453,521	-28,979 Reduced 30.5%	66,021 $926,000
Q2 2018 Aug 14, 2018	BUY	$15.3 - $19.69 $1.45 Million - $1.87 Million	95,000 New	95,000 $1.49 Million

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.43B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of U S Global Investors Inc, based on Form 13F filings with the SEC.

Stay updated on U S Global Investors Inc with notifications on news.